Company profile
Prestige Consumer Healthcare Inc.
NYSE: PBH · Healthcare · Medical - Distribution
#150 of 1,422 Healthcare companies by revenue35th-percentile growth
EA Score
78B+FH 82DQ 83GM 55SS 84
v0.1 · 65/100 weight · provisional
↑ operating margin, net margin · ↓ revenue growth (YoY), 3-yr revenue growth
Methodology →Revenue TTM
$1.1B
Rev growth YoY (TTM)
-4.3%
Net income (FY)
$190.3M
Employees
890
as of 2026-08-09
Market cap
$2.6B
as of 2026-08-09
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$1.1B$1.1B2026
Net income$190.3M$190.3M2026
Operating income$309.4M$309.4M2026
Total assets$3.5B$3.5B2026
Liabilities$1.6B$1.6B2026
Equity$1.9B$1.9B2026
Revenue trend
FY2020 – FY2026 · USD
FY20
FY20
FY21
FY22
FY23
FY24
FY25
FY26
Revenue by segment
Filed disclosures · FY2026
By product
Gastrointestinal24%
Women's Health21%
Eye and Ear Care13%
Dermatologicals12%
Analgesics10%
Cough and Cold9%
By geography
UNITED STATES78%
Non-US22%
The read
What is Prestige Consumer Healthcare Inc.’s revenue?
Prestige Consumer Healthcare Inc. booked $1.1B in FY2026 revenue, contracting 4.3% year over year — slower than 65% of Healthcare companies we track, at a 17.5% net margin.
Peers · Healthcare
Novavax, Inc.69BBabylon Holdings Limited——Waystar Holding Corp.70BEmbecta Corp.67BACADIA Pharmaceuticals Inc.82B+Bone Biologics Corporation45DNeighbors
Westchester →Key facts
CEORonald Lombardi
SectorHealthcare
IndustryMedical - Distribution
HeadquartersTarrytown, NY
ExchangeNYSE: PBH
Employees890
IPO date2005-02-10
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.